Evidence map›Paper›PMID 24887064›Full record

ArticlePloS one2014

Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.

Yvonne G van der Zwan, Martin A Rijlaarsdam, Fernando J Rossello, Amanda J Notini, Suzan de Boer, D Neil Watkins, Ad J M Gillis, Lambert C J Dorssers, Stefan J White, Leendert H J Looijenga

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yvonne G van der ZwanDepartment of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Martin A RijlaarsdamDepartment of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Fernando J RosselloCentre for Cancer Research, MIMR-PHI Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Amanda J NotiniCentre for Genetic Diseases, MIMR-PHI Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Suzan de BoerCentre for Genetic Diseases, MIMR-PHI Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
D Neil WatkinsCentre for Cancer Research, MIMR-PHI Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Ad J M GillisDepartment of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lambert C J DorssersDepartment of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Stefan J WhiteCentre for Genetic Diseases, MIMR-PHI Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Leendert H J LooijengaDepartment of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Erasmus MC · NLHudson Institute of Medical Research · AUMonash Institute of Medical Research · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOriginating from Primordial Germ Cells/gonocytes and developing via a precursor lesion called Carcinoma In Situ (CIS), Germ Cell Cancers (GCC) are the most common cancer in young men, subdivided in seminoma (SE) and non-seminoma (NS). During physiological germ cell formation/maturation, epigenetic processes guard homeostasis by regulating the accessibility of the DNA to facilitate transcription. Epigenetic deregulation through genetic and environmental parameters (i.e. genvironment) could disrupt embryonic germ cell development, resulting in delayed or blocked maturation. This potentially facilitates the formation of CIS and progression to invasive GCC. Therefore, determining the epigenetic and functional genomic landscape in GCC cell lines could provide insight into the pathophysiology and etiology of GCC and provide guidance for targeted functional experiments.

resultsThis study aims at identifying epigenetic footprints in SE and EC cell lines in genome-wide profiles by studying the interaction between gene expression, DNA CpG methylation and histone modifications, and their function in the pathophysiology and etiology of GCC. Two well characterized GCC-derived cell lines were compared, one representative for SE (TCam-2) and the other for EC (NCCIT). Data were acquired using the Illumina HumanHT-12-v4 (gene expression) and HumanMethylation450 BeadChip (methylation) microarrays as well as ChIP-sequencing (activating histone modifications (H3K4me3, H3K27ac)). Results indicate known germ cell markers not only to be differentiating between SE and NS at the expression level, but also in the epigenetic landscape.

conclusionThe overall similarity between TCam-2/NCCIT support an erased embryonic germ cell arrested in early gonadal development as common cell of origin although the exact developmental stage from which the tumor cells are derived might differ. Indeed, subtle difference in the (integrated) epigenetic and expression profiles indicate TCam-2 to exhibit a more germ cell-like profile, whereas NCCIT shows a more pluripotent phenotype. The results provide insight into the functional genome in GCC cell lines.

Indexed as

Epigenesis, GeneticGene Expression ProfilingCarcinoma, EmbryonalCell Line, TumorDNA MethylationHumansNeoplasms, Germ Cell and EmbryonalSeminoma

Identifiers

PMID24887064
PMCPMC4041891
OpenAlexW2165400010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.